Literature DB >> 21554617

Developmental aspect of differences in hypothalamic preproneuropeptide y messenger ribonucleic Acid content in lean and genetically obese zucker rats.

G Sanacora1, J A Finkelstein, J D Whitet.   

Abstract

The genetically obese Zucker rat is a well characterized model of early onset human obesity. Many of the endocrine and metabolic abnormalities of obese animals are common to other strains of genetically obese animals as well as morbidly obese humans. Neuropeptide Y (NPY), a potent orexigenic agent, was recently found to be elevated in adult obese animals compared to their lean littermates. In this study we first examined hypothalamic expression of preproNPY mRNA, using solution hybridization/ nuclease protection analysis, in phenotypically-matched, i.e. lean or obese, immature (5-week-old) and mature (33-week-old) animals. Although changes were not statistically different, a trend toward decreased hypothalamic preproNPY mRNA levels was detected in both lean and obese mature animals. We next compared hypothalamic preproNPY mRNA levels between age-matched lean and obese animals at 5, 14 and 33 weeks of age and found elevated preproNPY mRNA levels in obese rats at all three ages. These data suggest that increased levels of hypothalamic NPY are an early manifestation of the obese phenotype and may, therefore, contribute to hyperphagia and increased weight gain in obese Zucker rats.

Entities:  

Year:  1992        PMID: 21554617     DOI: 10.1111/j.1365-2826.1992.tb00179.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  4 in total

Review 1.  Neuropeptide Y in normal eating and in genetic and dietary-induced obesity.

Authors:  B Beck
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

2.  Plasma neuropeptide Y in impaired glucose tolerance.

Authors:  B Ahrén; H Larsson
Journal:  Acta Diabetol       Date:  1996-12       Impact factor: 4.280

Review 3.  Insulin, corticosterone and the autonomic nervous system in animal obesities: a viewpoint.

Authors:  B Jeanrenaud
Journal:  Diabetologia       Date:  1995-08       Impact factor: 10.122

4.  Induction and reversibility of an obesity syndrome by intracerebroventricular neuropeptide Y administration to normal rats.

Authors:  R Vettor; N Zarjevski; I Cusin; F Rohner-Jeanrenaud; B Jeanrenaud
Journal:  Diabetologia       Date:  1994-12       Impact factor: 10.122

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.